The manufacturing location for this product is nipro.This site is not registered with the fda.Therefore, (b)(6) registration number has been used for the manufacture report number.(b)(6).A sample is not available for evaluation.However, a no sample investigation and device history record review will be completed.Upon completion of the investigation, a supplemental report will be filed.
|
It was reported that the needle of a bd vacutainer® safety-lok¿ blood collection set separated from the tubing while taking the blood sample.The needle remained in the patient's arm, the tubing broke off from the needle, and blood leaked.There was no report of injury to the patient or clinician and there was no report of medical intervention.
|
Bd had not received samples, but photos were provided by the customer facility for investigation.The photos were evaluated and the customer's indicated failure mode for the tubing separating from the iv needle assembly with the incident lot was observed.A review of the device history record was completed for the incident lot and, based on this review, all product specifications and requirements for lot release were met; there were no related quality non-conformances during manufacturing of the product.Investigation conclusion: based on evaluation of the customer photos, the customer¿s indicated failure mode for tubing separating from the iv needle assembly with the incident lot was observed.Root cause description: based on the investigation, a root cause could not be determined.Rationale: complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.The bd business team regularly reviews the collected data for identification of emerging trends.
|